News
Photronics (PLAB) Just Reclaimed the 20-Day Moving Average
From a technical perspective, Photronics (PLAB) is looking like an interesting pick, as it just reached a key level of support. PLAB recently overtook the 20-day moving average, and this suggests a
DNOW (DNOW) Crossed Above the 20-Day Moving Average: What That Means for Investors
From a technical perspective, DNOW (DNOW) is looking like an interesting pick, as it just reached a key level of support. DNOW recently overtook the 20-day moving average, and this suggests a
Can Primoris's Data Center Strategy Power a New Phase of Growth?
Primoris Services Corporation PRIM is doubling down on a fast-rising growth market by positioning itself as a critical partner in the data center buildout. Management noted that Primoris is seeing
SAP Boosts AI-Driven Recruiting Innovation With SmartRecruiters Buyout
SAP SE (SAP) has officially completed its acquisition of SmartRecruiters, the Recruiting AI company. The ability to find, attract and engage the right talent directly influences organizational
4 Cloud Computing Stocks to Watch as Markets Hit Record High on a Trot
An updated edition of the July 28, 2025 article.Cloud computing has generated significant buzz across the business ecosystem, enabling firms to drive innovation and digital transformation
Wall Street Analysts See Constellation Energy Corporation (CEG) as a Buy: Should You Invest?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Wall Street Analysts Think Microsoft (MSFT) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Is Vistra (VST) a Buy as Wall Street Analysts Look Optimistic?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Wall Street Analysts See Agnico (AEM) as a Buy: Should You Invest?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Wall Street Analysts Think Chewy (CHWY) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Is It Worth Investing in Coupang (CPNG) Based on Wall Street's Bullish Views?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Goldman Sachs (GS) Boasts Earnings & Price Momentum: Should You Buy?
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium
Wall Street Analysts Think Sterling Infrastructure (STRL) Is a Good Investment: Is It?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Is TJX (TJX) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Earnings Growth & Price Strength Make MSCI (MSCI) a Stock to Watch
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
The Zacks Premium
Is It Worth Investing in Energy Fuels (UUUU) Based on Wall Street's Bullish Views?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)
Earnings Growth & Price Strength Make Alphabet (GOOGL) a Stock to Watch
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
One of our most popular
Brokers Suggest Investing in ServiceNow (NOW): Read This Before Placing a Bet
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm
Why Casey's General Stores (CASY) is a Top Stock for the Long-Term
Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.
One of our most popular
Elevance Health Shrinks to Grow Stronger: From Part D to Plan B?
Elevance Health, Inc. ELV is reshaping its Medicare strategy by stepping away from certain underperforming Medicare Advantage markets and fully exiting the standalone Part D segment. The move comes
Ciena's Stock Skyrockets 143% in 12 Months: Is More Upside Left?
Ciena Corporation’s (CIEN) shares have jumped 143% in the past year, outperforming the Zacks Communication-Components industry, the Zacks Computer and Technology sector and the S&P 500 composite’s
Ford Rises 23% in 6 Months: Should You Buy, Sell or Hold the Stock?
Ford Motor Company F shares have gained 23.4% over the past six months compared to the Zacks Automotive – Domestic industry’s growth of 38.4%. In the past six months, Ford has outperformed electric
Can D.R. Horton Defend Its Market Share as Competitors Expand?
D.R. Horton, Inc. (DHI), the nation’s largest homebuilder, posted a solid fiscal third-quarter 2025 performance with EPS of $3.36, beating the Zacks Consensus Estimate of $2.90 despite revenues
AbbVie Settles Rinvoq Patent Dispute: What It Means for the Stock
Shares of AbbVie ABBV rose over 4% to a record high on Thursday after the company announced that it had settled patent litigation with all generic manufacturers who had sought the FDA’s approval for


